Dyslipidaemia and statin use in individuals aged 10 to < 40 years in the T1D Exchange clinic registry

Creator(s)

Sarah K. Lyons
Claire T. Boyle
Daniel J. DeSalvo
Michael R. Rickels
Lauren K. Wood Heickman
Kellee M. Miller
Nicole C. Foster
Mark A. Clements, Children's Mercy HospitalFollow
T1D Exchange Clinic Network

Document Type

Article

Publication Date

1-2019

Identifier

DOI: 10.1111/dom.13475; PMCID: PMC7059116

Abstract

For individuals aged 10 todyslipidaemia, US national guidelines recommend consideration of statin therapy based on age, low-density lipoprotein cholesterol (LDL-C) level and other cardiovascular risk factors. We evaluated dyslipidaemia prevalence, statin therapy use, and associations between not meeting target LDL-C [/dL (

Journal Title

Diabetes, obesity & metabolism

Volume

21

Issue

1

First Page

170

Last Page

172

MeSH Keywords

Adolescent; Adult; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; United States; Young Adult

Keywords

dyslipidaemia; type 1 diabetes

Comments

Grant support

• K23 DK107937/DK/NIDDK NIH HHS/United States

Recommended Citation

Lyons SK, Boyle CT, DeSalvo DJ, et al. Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry. Diabetes Obes Metab. 2019;21(1):170-172. doi:10.1111/dom.13475